Track Phreesia, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Phreesia, Inc. PHR · Stock Open Phreesia, Inc. in new tab

10.07 USD
P/E
55.78
EPS
0.18
P/B
1.68
ROE
3.12
Beta
0.86
Target Price
13.94 USD
Phreesia, Inc. logo

Phreesia, Inc.

🧾 Earnings Recap – Q2 2027

Shares fell 6.2% as investors reacted to sequential revenue deceleration driven by seasonal payment processing declines and a cautious outlook for modest growth in revenue per client. Despite margin expansion and debt reduction, the lack of upward revision to growth targets and muted guidance weighed on sentiment.

  • Q2 revenue grew 10% year-over-year to $129.5 million but declined about 1% sequentially, primarily due to seasonality in legacy payment processing.
  • Adjusted EBITDA rose $10.8 million year-over-year to $32.9 million, with a 25% margin reflecting operational leverage.
  • Average health care services clients increased by 36 sequentially to 4,744, supporting expected mid-single-digit AHSC growth for fiscal 2027.
  • Revenue per client rose 4% year-over-year but declined about 2% from Q1, reflecting payment processing seasonality and modest growth expectations.
  • Fiscal 2027 guidance was maintained at $510-$520 million revenue and $125-$135 million adjusted EBITDA, indicating no upside surprise amid ongoing restructuring and cautious optimism.
📅
Loading chart...
Key Metrics
Earnings dateDec. 14, 2026
P/E55.78
EPS0.18
Book Value5.99
Price to Book1.68
Debt/Equity18.27
% Insiders6.316%
Growth
Revenue Growth0.10%
Earnings Growth2.00%
Estimates
Forward P/E6.25
Forward EPS1.61
Target Mean Price13.94

DCF Valuation

Tweak assumptions to recompute fair value for Phreesia, Inc. (PHR)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Phreesia, Inc. Logo Phreesia, Inc. Analysis (PHR)

United States Health Care Official Website Stock

Is Phreesia, Inc. a good investment? Phreesia, Inc. (PHR) is currently trading at 10.07 USD. Market analysts have a consensus price target of 13.94 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 55.78. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Phreesia, Inc. is expected to release its next earnings report on Dec. 14, 2026. The market consensus estimate for Forward EPS is 1.61.

Investor FAQ

Does Phreesia, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Phreesia, Inc.?

Phreesia, Inc. is classified as a Stock. You can compare it against 3 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Dec. 14, 2026. The company currently has a trailing EPS of 0.18.

Company Profile

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. It offers solutions including appointment optimization and referral management using AI-enabled workflows; and AI-based smart answering solution patient communications supported by voice and messaging solutions; integrated payment solutions embedded in intake and post-visit workflows, and financing solutions that enable healthcare organizations to accelerate cash collections while offering flexible payment options to patients; and digital intake and clinical data capture, patient engagement and activation tools, and measurement and analytics solutions. It also offers PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, which are on-site kiosks. The company serves a range of healthcare organizations including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest and not-for-profit and other organizations. Phreesia, Inc. was incorporated in 2005 and is based in Wilmington, Delaware.

Exchange Ticker
NYQ (United States) PHR
LSE (United Kingdom) 0A23.L
FRA (Germany) 19P.F
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion